Well-defined melanoma antigens as progression markers for melanoma: Insights into differential expression and host response based on stage

被引:33
作者
Hodi, FS
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
10.1158/1078-0432.CCR-05-2616
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:673 / 678
页数:6
相关论文
共 71 条
[1]   Immunogenicity of constitutively active V599EBRaf [J].
Andersen, MH ;
Fensterle, J ;
Ugurel, S ;
Reker, S ;
Houben, R ;
Guldberg, P ;
Berger, TG ;
Schadendorf, D ;
Trefzer, U ;
Bröcker, EB ;
Straten, PT ;
Rapp, UR ;
Becker, JC .
CANCER RESEARCH, 2004, 64 (15) :5456-5460
[2]   Current developments of immunotherapy in the clinic [J].
Antonia, S ;
Mulé, JJ ;
Weber, JS .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (02) :130-136
[3]   Tumor antigen expression in melanoma varies according to antigen and stage [J].
Barrow, C ;
Browning, J ;
MacGregor, D ;
Davis, ID ;
Sturrock, S ;
Jungbluth, AA ;
Cebon, J .
CLINICAL CANCER RESEARCH, 2006, 12 (03) :764-771
[4]   CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin [J].
Basu, S ;
Binder, RJ ;
Ramalingam, T ;
Srivastava, PK .
IMMUNITY, 2001, 14 (03) :303-313
[5]  
Berger AJ, 2003, CANCER RES, V63, P8103
[6]   An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis [J].
Bhoumik, A ;
Huang, TG ;
Ivanov, V ;
Gangi, L ;
Qiao, RF ;
Woo, SLC ;
Chen, SH ;
Ronai, Z .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (05) :643-650
[7]   BAGE - A NEW GENE ENCODING AN ANTIGEN RECOGNIZED ON HUMAN MELANOMAS BY CYTOLYTIC T-LYMPHOCYTES [J].
BOEL, P ;
WILDMANN, C ;
SENSI, ML ;
BRASSEUR, R ;
RENAULD, JC ;
COULIE, P ;
BOON, T ;
VANDERBRUGGEN, P .
IMMUNITY, 1995, 2 (02) :167-175
[8]   NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: A tissue microarray study [J].
Bolli, M ;
Schultz-Thater, E ;
Zajac, P ;
Guller, U ;
Feder, C ;
Sanguedolce, F ;
Carafa, V ;
Terracciano, L ;
Hudolin, T ;
Spagnoli, GC ;
Tornillo, L .
INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (06) :960-966
[9]   EXPRESSION OF MAGE GENES IN PRIMARY AND METASTATIC CUTANEOUS MELANOMA [J].
BRASSEUR, F ;
RIMOLDI, D ;
LIENARD, D ;
LETHE, B ;
CARREL, S ;
ARIENTI, F ;
SUTER, L ;
VANWIJCK, R ;
BOURLOND, A ;
HUMBLET, Y ;
VACCA, A ;
CONESE, M ;
LAHAYE, T ;
DEGIOVANNI, G ;
DERAEMAECKER, R ;
BEAUDUIN, M ;
SASTRE, X ;
SALAMON, E ;
DRENO, B ;
JAGER, E ;
KNUTH, A ;
CHEVREAU, C ;
SUCIU, S ;
LACHAPELLE, JM ;
POUILLART, P ;
PARMIANI, G ;
LEJEUNE, F ;
CEROTTINI, JC ;
BOON, T ;
MARCHAND, M .
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (03) :375-380
[10]   THE TYROSINASE GENE CODES FOR AN ANTIGEN RECOGNIZED BY AUTOLOGOUS CYTOLYTIC T-LYMPHOCYTES ON HLA-A2 MELANOMAS [J].
BRICHARD, V ;
VANPEL, A ;
WOLFEL, T ;
WOLFEL, C ;
DEPLAEN, E ;
LETHE, B ;
COULIE, P ;
BOON, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) :489-495